Stock A216080 JETEMA, CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company JETEMA, Co., Ltd.

Equities

A216080

KR7216080002

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
15,600 KRW -1.89% Intraday chart for JETEMA, Co., Ltd. -0.06% +0.32%
2023 JETEMA, Co., Ltd. announced that it has received KRW 56 billion in funding from Korea Investment Partners Co. Ltd. CI
2023 JETEMA, Co., Ltd. announced that it expects to receive KRW 56 billion in funding from Korea Investment Partners Co. Ltd. and other investor CI

Business Summary

JETEMA. CO,.LTD is a Korea-based company principally engaged in the development and manufacturing of hyaluronic acid fillers used for facial beauty and other medical devices. The Company manufactures and sells medical devices for improvement of wrinkle, contour and volume. In addition, the Company also engages in the manufacturing and sale of laser equipment used for treatment of leukoplakia, psoriasis and alopecia areata, lifting medical device epiticons, cosmetic mask packs, pharmaceutical excaine creams as well as others.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Filler
62.4 %
31,412 68.3 % 36,645 62.4 % +16.66%
Toxin
29.3 %
10,638 23.1 % 17,184 29.3 % +61.53%
Other
6.7 %
3,709 8.1 % 3,949 6.7 % +6.47%
Rental
1.6 %
234 0.5 % 939 1.6 % +300.47%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
45,994 100.0 % 58,716 100.0 % +27.66%

Managers

Managers TitleAgeSince
Jae-Young Kim CEO
 Chief Executive Officer 56 -

Members of the board

Members of the board TitleAgeSince
Jae-Young Kim CEO
 Chief Executive Officer 56 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,858,759 12,415,277 ( 69.52 %) 0 69.52 %

Shareholders

NameEquities%Valuation
Jae-Young Kim
23.71 %
4,233,600 23.71 % 44 M ₩
Jeong-Sun Nam
1.795 %
320,619 1.795 % 3 M ₩
V-ONE TECH CO., LTD.
1.227 %
219,200 1.227 % 2 M ₩
Geum-ran Jang
1.091 %
194,800 1.091 % 2 M ₩
Hana Financial Investment Co., Ltd. /Private Equity/
0.7405 %
132,238 0.7405 % 1 M ₩
Hyung-seok Kim
0.6719 %
120,000 0.6719 % 1 M ₩
DONGWHA PHARM.CO.,LTD
0.6159 %
110,000 0.6159 % 1 M ₩
Beom-Jin Yoon
0.5935 %
106,000 0.5935 % 1 M ₩
Sang-joon Park
0.3880 %
69,300 0.3880 % 713 976 ₩
Beom-joon Kim
0.3274 %
58,478 0.3274 % 602 481 ₩

Company contact information

Jetema Co., Ltd.

321 Joeom-ro Jijeong-myeon

26355, Wonju

+

http://www.jetema.com
address JETEMA, Co., Ltd.(A216080)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Ratings for JETEMA, Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
JETEMA, CO., LTD. Stock JETEMA, Co., Ltd.
+0.32% 208M
CSL LIMITED Stock CSL Limited
-2.61% 88.47B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+3.55% 40.71B
BIOGEN INC. Stock Biogen Inc.
-14.07% 32.43B
UCB Stock UCB
+55.89% 24.28B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.21% 15.52B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-41.29% 12.17B
INCYTE CORPORATION Stock Incyte Corporation
-15.46% 12.01B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.75% 12B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+7.87% 8.87B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A216080 Stock
  4. Company JETEMA, Co., Ltd.